$55 Million is the total value of IDG-Accel China Growth Fund III Associates L.P.'s 6 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JG | AURORA MOBILE LTDads | $21,268,000 | -23.2% | 6,544,065 | 0.0% | 38.68% | +3.6% | |
| CASI | CASI PHARMACEUTICALS INC | $12,359,000 | -35.4% | 7,973,536 | 0.0% | 22.48% | -12.9% | |
| SECO | SECOO HLDG LTDadr | $10,289,000 | -2.8% | 4,182,702 | 0.0% | 18.72% | +31.1% | |
| LAIX | LAIX INCads | $4,268,000 | -26.2% | 2,294,731 | 0.0% | 7.76% | -0.4% | |
| MOGU | MOGU INCspon ads | $3,510,000 | -14.4% | 2,114,245 | 0.0% | 6.38% | +15.4% | |
| AIH | Sell | AESTHETIC MED INTL HLDG GR Lads | $3,283,000 | -52.2% | 412,468 | -55.8% | 5.97% | -35.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AURORA MOBILE LTD | 8 | Q3 2021 | 45.2% |
| CASI PHARMACEUTICALS INC | 8 | Q3 2021 | 30.4% |
| SECOO HLDG LTD | 8 | Q3 2021 | 20.3% |
| LAIX INC | 8 | Q3 2021 | 10.4% |
| AESTHETIC MED INTL HLDG GR L | 8 | Q3 2021 | 9.3% |
| MOGU INC | 8 | Q3 2021 | 9.0% |
| BILIBILI INC | 3 | Q2 2020 | 60.5% |
| NIU TECHNOLOGIES | 3 | Q2 2020 | 4.6% |
View IDG-Accel China Growth Fund III Associates L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-06-03 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-10 |
| 13F-HR | 2020-08-05 |
| 13F-HR | 2020-06-05 |
| 13F-HR/A | 2020-03-06 |
| 13F-HR | 2020-02-14 |
| 4 | 2018-03-23 |
View IDG-Accel China Growth Fund III Associates L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.